Case Control Study
Copyright ©The Author(s) 2024.
World J Diabetes. Feb 15, 2024; 15(2): 196-208
Published online Feb 15, 2024. doi: 10.4239/wjd.v15.i2.196
Table 3 Test results of observation and control groups
Items
Observation group (n = 105)
Control group (n = 210)
χ2/t
P value
Height (cm)169.52 ± 8.81168.68 ± 7.540.8810.379
Weight (kg)66.53 ± 13.6271.75 ± 12.08-3.2490.001
Body mass index (kg/m2)23.00 ± 3.3025.18 ± 3.40-5.377< 0.001
Systolic blood pressure (mmHg)129.00 ± 20.00134.00 ± 24.00-2.5440.011
Diastolic blood pressure (mmHg)80.00 ± 10.5083.00 ± 14.00-2.5040.012
Hemoglobin A1c (%)8.85 ± 2.158.90 ± 2.80-0.8730.382
Fasting blood glucose (mmol/L)10.54 ± 3.437.83 ± 2.81-4.517< 0.001
Hemoglobin (g/L)136.50 ± 27.00138.00 ± 21.00-0.2950.768
Albumin (g/L)40.20 ± 8.4039.68 ± 5.80-0.2470.805
Lymphocyte count (109/L)1.65 ± 0.782.08 ± 0.94-4.168< 0.001
Triglyceride (mmol/L)1.28 ± 0.311.47 ± 0.36-1.9400.052
Cholesterol (mmol/L)4.68 ± 1.134.39 ± 1.62-1.8700.061
High-density lipoprotein (mmol/L)1.20 ± 0.471.10 ± 0.39-2.0320.042
Low-density lipoprotein (mmol/L)2.85 ± 1.082.70 ± 1.30-0.7130.476